1 of 1
Story summary
- AstraZeneca and Oracle Health have entered a nonbinding AI collaboration to improve trial recruitment and patient care.
- Announced on October 20, 2026, the partnership will launch an Abu Dhabi AI pilot to identify patients with uncontrolled hypertension.
- The Abu Dhabi pilot seeks to increase trial enrollment for hypertension patients.
- Oracle Health will supply AI tools and embed research findings into clinical consultations under privacy safeguards.